CEPH Message Board - Msg: 1416729

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rocketman who wrote (336)	5/16/1997 6:39:00 AM
From: harkenman	of 998

According to your numbers they only are making 10% of your lowest estimate e.g. $28 million vs your estimate of $273 million. I was told that Rilutek sells for $25 tablet. I am going to check today with a local drugstore price per tablet to make sure. from there we estimate the wholesale price and from there we get market potential. You can always check yourself. The $28 million is an offical RPR published number in one of their SEC filings! FYI Just wanted for you to realize what a blockbuster market you are going to exploit. So if we extrapolate, multiply the highest or lowest myo market potential by 10%. This is the reality of the market. Based on the negative european study, drug effectiveness can be estimated to be lower than Rilutek, so expect a lower market penetration than Rilutek based on FDA evaluation/clinical results. IMO.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next